DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Protonix (Pantoprazole) - Adverse Event Reports - Death - Malignant Neoplasm Progression

 



Index of reports > Cases resulting in death (5) > Cases with Malignant Neoplasm Progression (1)

Below is the selection of adverse event reports related to Protonix (Pantoprazole) that includes cases resulting in death where reactions include malignant neoplasm progression.

Adverse event in 69 year old male receiving Protonix (Pantoprazole)

Reported by a physician from United States on 2007-01-31

Patient: 69 year old male

Adverse reactions / side effects: Malignant Neoplasm Progression, Platelet Count Decreased, Blood Count Abnormal, Multiple Myeloma, Cardiac Disorder

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Actos
    Indication: Drug USE FOR Unknown Indication

Coumadin
    Indication: Drug USE FOR Unknown Indication

Insulin (Insulin)
    Indication: Drug USE FOR Unknown Indication

Lisinopril
    Indication: Drug USE FOR Unknown Indication

Protonix
    Indication: Drug USE FOR Unknown Indication

Revlimid
    Dosage: 25 mg, 3 weeks on, 1 week off, oral
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2006-07-10
    End date: 2006-12-08

Revlimid

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009